Evolutionary theory of cancer

Annals of the New York Academy of Sciences

Volumn 1168, Issue , 2009, Pages 23-51

  Attolini, Camille Stephan Otto ^a   Michor, Franziska ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Evolution; Mathematical modeling

Indexed keywords

CARCINOGENESISS; IMATINIB; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; EVOLUTION; HUMAN; MATHEMATICAL MODEL; MUTATOR GENE; NEOPLASM; NONHUMAN; PHENOTYPE; REVIEW; STEM CELL;

EID: 67649798606     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04880.x     Document Type: Review

References (133)

1. Angerer, W. P. (2001). An explicit representation of the Luria-Delbrück distribution. Journal of Mathematical Biology, 42, 145 174.
2. Armitage, P., & Doll, R. (1957). A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer, 11, 161 169.
3. Ashley, D. J. (1969). Colonic cancer arising in polyposis coli. Journal of Medical Genetics, 6, 376 378.
4. Axelrod, R., Axelrod, D. E., & Pienta, K. J. (2006). Evolution of cooperation among tumor cells. Proc. Natl. Acad. Sci. USA, 103, 13474 13479.
5. Bach, S. P., Renehan, A. G., & Potten, C. S. (2000). Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis, 21, 469 476.
6. Beckman, R. A., & Loeb, L. A. (2005). Negative clonal selection in tumor evolution. Genetics, 171, 2123 2131.
7. Beerenwinkel, N. (2005). Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics, 21, 2106 2107.
8. Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., et al 2007). Genetic progression and the waiting time to cancer. PLoS Comput. Biol., 3, e225.
9. Bernoulli, D., & Blower, S. (2004). An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it. 1766. Rev. Med. Virol., 14, 275 288.
10. Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., et al 2007). Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA, 104, 20007 20012.
11. Bodmer, W., & Tomlinson, I. (1995). Failure of programmed cell death and differentiation as causes of tumors: Some simple mathematical models. Proc. Natl. Acad. Sci. USA : 11130 11134.
12. Boveri, T. (1914). Zur Frage der Entstehung maligner Tumoren. Jena, Germany : Verlag G. Fischer.
13. Brumer, Y., Michor, F., & Shakhnovich, E. I. (2006). Genetic instability and the quasispecies model. J. Theor. Biol., 241, 216 222.
14. Buss, L. W. (1987). The evolution of individuality. Princeton, NJ : Princeton University Press.
15. Cairns, J. (1975). Mutation selection and the natural history of cancer. Nature, 255, 197 200.
16. Cairns, J. (2002). Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl. Acad. Sci. USA, 99, 10567 10570.
17. Charles, D., & Luce-Clausen, E. (1942). The kinetics of papilloma formation in benzpyrene-treated mice. Cancer Research, 2, 261 263.
18. Chittenden, T. W., Howe, E. A., Culhane, A. C., & Sultana, R. (2008). Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics, 91, 508 511.
19. Coldman, A. J., & Goldie, J. H. (1986). A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bull. Math. Biol., 48, 279 292.
20. Coldman, A. J., & Murray, J. M. (2000). Optimal control for a stochastic model of cancer chemotherapy. Mathematical Biosciences, 168, 187 200.
21. Conboy, M. J., Karasov, A. O., & Rando, T. A. (2007). High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. Plos Biol., 5, e102.
22. Basanta, D., Simon, M., Hatzikirou, H., & Deutsch, A. 2008. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Proliferation, 41, 980 987.
23. d'Onofrio, A., & Tomlinson, I. P. (2007). A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J. Theor. Biol., 244, 367 374.
24. Desper, R., Jiang, F., Kallioniemi, O. P., Moch, H., Papadimitriou, C. H., & Schäffer, A. A. (1999). Inferring tree models for oncogenesis from comparative genome hybridization data. J. Comput. Biol., 6, 37 51.
25. Dewanji, A., Luebeck, E. G., & Moolgavkar, S. H. (2005). A generalized Luria-Delbrück model. Mathematical Biosciences, 197, 140 152.
26. Dingli, D., Michor, F., Antal, T., & Pacheco, J. M. (2007a). The emergence of tumor metastases. Cancer Biol. Ther., 6, 383 390.
27. Dingli, D., Traulsen, A., & Pacheco, J. M. (2007b). Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle, 6, 461 466.
28. Dobzhansky, T. (1973). Nothing in biology makes sense except in the light of evolution. American Biology Teacher, 35, 125 129.
29. Eigen, M., & Schuster, P. (1977). The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle. Naturwissenschaften, 64, 541 565.
30. Enderling, H., Chaplain, M. A., Anderson, A. R., & Vaidya, J. S. (2007). A mathematical model of breast cancer development, local treatment and recurrence. J. Theor. Biol., 246, 245 259.
31. Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759 767.
32. Fisher, J. C. (1958). Multiple-mutation theory of carcinogenesis. Nature, 181, 651 652.
33. Fisher, J. C., & Hollomon, J. H. (1951). A hypothesis for the origin of cancer foci. Cancer, 4, 916 918.
34. Forrest, W. F., & Cavet, G. (2007). Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers." Science, 317, 1500b.
35. Frank 2003). Somatic mosaicism and cancer: inference based on a conditional Luria-Delbrück distribution. J. Theor. Biol., 223, 405 412.
36. Frank 2004a). Genetic predisposition to cancer - insights from population genetics. Nat. Rev. Genet., 5, 764 772.
37. Frank 2004b). Genetic variation in cancer predisposition: mutational decay of a robust genetic control network. Proc. Natl. Acad. Sci. USA, 101, 8061 8065.
38. Frank (2005). Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proc. Natl. Acad. Sci. USA, 102, 1071 1075.
39. Frank (2007). Dynamics of cancer: Incidence, inheritance, and evolution. Princeton, NJ : Princeton University Press.
40. Frank, Iwasa, Y., & Nowak, M. A. (2003). Patterns of cell division and the risk of cancer. Genetics, 163, 1527 1532.
41. Friend, S. H., Bernards, R., Rogelj, S., & Weinberg, R. A. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature, 323, 643 646.
42. Gatenby, R. A., & Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nat. Rev. Cancer, 8, 56 61.
43. Gatenby, R. A., & Maini, P. K. (2003). Mathematical oncology: cancer summed up. Nature, 421, 321.
44. Gatenby, R. A., & Vincent, T. L. (2003a). An evolutionary model of carcinogenesis. Cancer Research, 63, 6212 6220.
45. Gatenby, R. A., & Vincent, T. L. (2003b). Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol. Cancer Ther., 2, 919 927.
46. Getz, G., Hofling, H., Mesirov, J., Golub, T., Meyerson, M., Tibshirani, R., & Lander, E. (2007). Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers". Science, 317, 1500.
47. Goldie, J. H., & Coldman, A. J. (1983). Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treatment Reports, 67, 923 931.
48. Goldie, J. H., & Coldman, A. J. (1984). The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Research, 44, 3643 3653.
49. González-García, I., Solé, R. V., & Costa, J. (2002). Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl. Acad. Sci. USA, 99, 13085 13089.
50. Haeno, H., Iwasa, Y., & Michor, F. (2007). The evolution of two mutations during clonal expansion. Genetics, 177, 2209 2221.
51. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57 70.
52. Herrero-Jimenez, P., Tomita-Mitchell, A., & Furth, E. E. (2000). Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 447, 73 116.
53. Iwasa, Y., Michor, F., & Nowak, M. A. (2003). Evolutionary dynamics of escape from biomedical intervention. Proc. Biol. Sci., 270, 2573 2578.
54. Iwasa, Y., Michor, F., & Nowak, M. A. (2004). Stochastic tunnels in evolutionary dynamics. Genetics, 166, 1571 1579.
55. Iwasa, Y., Nowak, M. A., & Michor, F. (2006). Evolution of resistance during clonal expansion. Genetics, 172, 2557 2566.
56. Jallepalli, P. V., & Lengauer, C. (2001). Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer, 1, 109 117.
57. Johnston, M. D., Edwards, C. M., Bodmer, W. F., Maini, P. K., & Chapman, S. J. (2007). Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. USA, 104, 4008 4013.
58. Jones, S., Chen, W. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., et al 2008). Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA, 105, 4283 4288.
59. Kiel, M. J., He, S., Ashkenazi, R., Gentry, S. N., & Teta, M. (2007). Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature, 449, 238 243.
60. Kimura, M. (1968). Evolutionary rate at the molecular level. Nature, 217, 624 626.
61. Kinzler, K. W., & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell, 87, 159 170.
62. Knudson, A. G. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820 823.
63. Knudson, A. G. (1986). Genetics of Human Cancer. Annual Reviews in Genetics, 20, 231 251.
64. Knudson, A. G. (2001). Two genetic hits (more or less) to cancer. Nat. Rev. Cancer, 1, 157 162.
65. Kolodner, R. D., Putnam, C. D., & Myung, K. (2002). Maintenance of Genome Stability in Saccharomyces cerevisiae. Science, 297, 552 557.
66. Komarova, N. L., Sengupta, A., & Nowak, M. A. (2003). Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J. Theor. Biol., 223, 433 450.
67. Komarova, N. L., & Wodarz, D. (2003). Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. Cancer Research, 63, 6635 6642.
68. Komarova, N. L., & Wodarz, D. (2004). The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proc. Natl. Acad. Sci. USA, 101, 7017 7021.
69. Komarova, N. L., & Wodarz, D. (2005). Drug resistance in cancer: principles of emergence and prevention. Proc. Natl. Acad. Sci. USA, 102, 9714 9719.
70. Komarova, N. L., & Wodarz, D. (2007). Effect of cellular quiescence on the success of targeted CML therapy. PLoS ONE, 2, e990.
71. Komarova, N. L., Wu, L., & Baldi, P. (2007). The fixed-size Luria-Delbruck model with a nonzero death rate. Mathematical Biosciences, 210, 253 290.
72. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature, 386, 623 627.
73. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998). Genetic Instabilities In human cancers. Nature, 396, 643 649.
74. Liso, A., Castiglione, F., Cappuccio, A., & Stracci, F. (2008). A one-mutation mathematical model can explain the age incidence of AML with mutated nucleophosmin (NPM1). Haematologica, 93, 1219 1226.
75. Loeb, L. A. (1991). Mutator phenotype may be required for multistage carcinogenesis. Cancer Research, 51, 3075 3079.
76. Luebeck, E. G., & Moolgavkar, S. H. (2002). Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences, 99, 15095 15100.
77. Luria, S. E., & Delbrück, M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics, 28, 491 511.
78. Maley, C., Galipeau, P., Finley, J., Wongsurawat, V., Li, X., Sanchez, C., et al 2006). Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet., 38, 468 473.
79. Maley, C., Galipeau, P., Li, X., Sanchez, C., Paulson, T., & Reid, B. (2004a). Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Research, 64, 3414 3427.
80. Maley, C., Reid, B., & Forrest, S. (2004b). Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol. Biomarkers Prev., 13, 1375 1384.
81. Maley, C. C., & Forrest, S. (2001). Exploring the relationship between neutral and selective mutations in cancer. Artif. Life, 6, 325 345.
82. Merlo, L. M., Pepper, J., Reid, B., & Maley, C. (2006). Cancer as an evolutionary and ecological process. Nat. Rev. Cancer, 6, 924 935.
83. Michor, F., Frank, May, R. M., Iwasa, Y., & Nowak, M. A. (2003a). Somatic selection for and against cancer. J. Theor. Biol., 225, 377 382.
84. Michor, F., Hughes, T. P., Iwasa, Y., Branford, S., Shah, N. P., Sawyers, C. L., et al 2005a). Dynamics of chronic myeloid leukaemia. Nature, 435, 1267 1270.
85. Michor, F., & Iwasa, Y. (2006). Dynamics of metastasis suppressor gene inactivation. J. Theor. Biol., 241, 676 689.
86. Michor, F., Iwasa, Y., Lengauer, C., & Nowak, M. A. (2005b). Dynamics of colorectal cancer. Semin. Cancer Biol., 15, 484 493.
87. Michor, F., Iwasa, Y., & Nowak, M. A. (2004a). Dynamics of cancer progression. Nat. Rev. Cancer, 4, 197 205.
88. Michor, F., Iwasa, Y., & Nowak, M. A. (2006a). The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc. Natl. Acad. Sci. USA, 103, 14931 14934.
89. Michor, F., Iwasa, Y., Rajagopalan, H., Lengauer, C., & Nowak, M. A. (2004b). Linear model of colon cancer initiation. Cell Cycle, 3, 358 362.
90. Michor, F., Nowak, M. A., Frank, & Iwasa, Y. (2003b). Stochastic elimination of cancer cells. Proc. Biol. Sci., 270, 2017 2024.
91. Michor, F., Nowak, M. A., & Iwasa, Y. (2006b). Evolution of resistance to cancer therapy. Curr. Pharm. Des., 12, 261 271.
92. Michor, F., Nowak, M. A., & Iwasa, Y. (2006c). Stochastic dynamics of metastasis formation. J. Theor. Biol., 240, 521 530.
93. Nagy, J. D. (2004). Competition and natural selection in a mathematical model of cancer. Bull. Math. Biol., 66, 663 687.
94. Nagy, J. D., Victor, E. M., & Cropper, J. H. (2007). Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox. Integr. Comp. Biol. doi :.
95. Newton, M. A. (2002). Discovering Combinations of Genomic Aberrations Associated With Cancer. Journal of the American Statistical Association, 97, 931 942.
96. Nordling, C. O. (1953). A new theory on cancer-inducing mechanism. Br. J. Cancer, 7, 68 72.
97. Norton, L., & Simon, R. (1977) Growth curve of an experimental solid tumor following radiotherapy. J. Natl. Cancer Inst., 58, 1735 1741.
98. Nowak, M. A., Komarova, N. L., Sengupta, A., & Jallepalli, P. V. (2002). The role of chromosomal instability in tumor initiation. Proc. Natl. Acad.f Sci. USA, 99, 16226 16231.
99. Nowak, M. A., Michor, F., & Iwasa, Y. (2003). The linear process of somatic evolution. Proc. Natl. Acad. Sci. USA, 100, 14966 14969.
100. Nowak, M. A., Michor, F., Komarova, N. L., & Iwasa, Y. (2004). Evolutionary dynamics of tumor suppressor gene inactivation. Proc. Natl. Acad. Sci. USA, 101, 10635 10638.
101. Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science, 194, 23 28.
102. Nunney, L. (2003). The population genetics of multistage carcinogenesis. Proc. Biol. Sci., 270, 1183 1191.
103. Parmigiani, G., Lin, J., Boca, S. M., Sjoblom, T., & Jones, S. (2007). Response to Comments on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers." Science, 317, 1500.
104. Pepper, J., Sprouffske, K., & Maley, C. (2007). Animal cell differentiation patterns suppress somatic evolution. PLoS Comput. Biol., 3, e250.
105. Perucho, M. (1996). Cancer of the microsatellite mutator phenotype. Biol. Chem., 377, 675 684.
106. Prioreschi, P. (2002). Al-Kindi, A Precursor Of The Scientific Revolution. ISHIM, 1, 17 20.
107. Rajagopalan, H., Nowak, M. A., Vogelstein, B., & Lengauer, C. (2003). The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer, 3, 695 701.
108. Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003). A molecular signature of metastasis in primary solid tumors. Nat. Genet., 33, 49 54.
109. Reva, B., Antipin, Y., & Sander, C. (2007). Determinants of protein function revealed by combinatorial entropy optimization. Genome Biol., 8, R232.
110. Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105 111.
111. Rubin, A. F., & Green, P. (2007). Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers." Science, 317, 1500c.
112. Sarkar, S. (1991). Haldane's Solution of the Luria-Delbruck Distribution. Genetics, 127, 257 261.
113. Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., et al 2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268 274.
114. Skipper, H. E. (1983). The forty-year-old mutation theory of Luria and Delbruck and its pertinence to cancer chemotherapy. Adv. Cancer Res., 40, 331 363.
115. Skipper, H. E., Schabel, Jr., F. M., & Wilcox, W. (1964). Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother. Rep., 35, 1 111.
116. Smith, G., Carey, F. A., Beattie, J., Wilkie, M. J., Lightfoot, T. J., Coxhead, J., et al 2002). Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc. Natl. Acad. Sci. USA, 99, 9433 9438.
117. Solé, R. V., & Deisboeck, T. (2004). An error catastrophe in cancer? J. Theor. Biol., 228, 47 54.
118. Taylor, B., Barretina, J., Socci, N. D., DeCarolis, P., & Sander, C. (2008). Functional Copy-number Alterations in Cancer. PLoS ONE, 3, e3179.
119. TCGA, T. C. G. A. R. N. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061 1068.
120. Tomlinson, I. P., Novelli, M. R., & Bodmer, W. F. (1996). The mutation rate and cancer. Proc. Natl. Acad. Sci. USA, 93, 14800 14803.
121. Vincent, T. L., & Gatenby, R. A. (2008). An evolutionary model for initiation, promotion, and progression in carcinogenesis. Int. J. Oncol., 32, 729 737.
122. Vogelstein, B., & Kinzler, K. W. (2002). The genetic basis of human cancer. New York : McGraw-Hill.
123. von Heydebreck, A., Gunawan, B., & Füzesi, L. (2004). Maximum likelihood estimation of oncogenetic tree models. Biostatistics (Oxford, England), 5, 545 556.
124. Weinberg, R. A. (2007). The biology of cancer. London : Garland Science, Taylor and Francis.
125. Weinstein, I. B. (2002). CANCER: Addiction to oncogenes-the achilles heal of cancer. Science, 297, 63 64.
126. Weir, B., Woo, M., Getz, G., Perner, S., Ding, L., Beroukhim, R., et al 2007). Characterizing the cancer genome in lung adenocarcinoma. Nature, 450, 893 898.
127. Wodarz, D. (2001). Viruses as antitumor weapons defining conditions for tumor remission. Cancer Research, 61, 3501 3507.
128. Wodarz, D. (2007). Effect of stem cell turnover rates on protection against cancer and aging. J. Theor. Biol., 245, 449 458.
129. Wodarz, D., & Komarova, N. (2007). Can loss of apoptosis protect against cancer? Trends Genet., 23, 232 237.
130. Yuen, Leung, S. Y., Wooster, R., Futreal, P. A., & Stratton, M. R. (2007). Patterns of somatic mutation in human cancer genomes. Nature, 446, 153 158.
131. Zhang, L., Strouthos, C. G., Wang, Z., & Deisboeck, T. S. (2009). Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate. Mathematical and Computer Modelling, 49, 307 319.
132. Zheng, Q. (1999). Progress of a half century in the study of the Luria-Delbrück distribution. Mathematical Biosciences, 162, 1 32.
133. Zheng, Q. (2008). On Bartlett's formulation of the Luria-Delbrück mutation model. Mathematical Biosciences, 215, 48 54.